Top

European Radiology

Published in:

01-09-2015 | Breast

The Z0011 Trial: Is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients?

Authors: T. P. J. Farrell, N. C. Adams, M. Stenson, P. A. Carroll, M. Griffin, E. M. Connolly, S. A. O’Keeffe

Published in: European Radiology | Issue 9/2015

Abstract

Objectives

The Z0011 trial questioned the role of axillary ultrasound (AxUS) in preoperative staging of breast cancer in patients with ≤2 positive sentinel lymph nodes (SLN). The purpose of this study was to correlate the number of abnormal nodes on AxUS with final nodal burden and determine the utility of AxUS with sampling (AxUS + S) in preoperative staging.

Methods

Six hundred and seventy-nine patients underwent pre-operative AxUS. Suspicious nodes were sampled. Negative axillae proceeded to SLN biopsy. The number of abnormal nodes identified on ultrasound and final histology as well as sensitivity and specificity for AxUS + S were calculated. Subgroup analysis was performed on Z0011 eligible patients.

Results

Two hundred and ninety-six patients had positive axillary nodes on final histology with 169 detected by AxUS + S (sensitivity 86.2 %, specificity 100 %, PPV 100 %, NPV 71.9 %). Patients with nodal metastases identified by AxUS had a mean burden of 7.3 nodes on histology (1 node on AxUS = 5.2 nodes on histology, 2 nodes on AxUS = 7.5 nodes, >2 nodes = 10.1 nodes). Patients diagnosed on SLNB had a mean burden of 2.2 nodes.

Conclusion

A single nodal metastasis detected on AxUS + S correlated with a mean of 5.2 nodes on final histology highlighting that AxUS remains essential in guiding appropriate management of the axilla in breast cancer.

Key Points

• Axillary ultrasound +/- sampling is an essential technique in preoperative axillary staging.

• Axillary ultrasound findings correlate with final histological axillary node disease burden.

• Axillary ultrasound can help triage patients who require axillary lymph node dissection.

• The role of axillary ultrasound in breast cancer staging continues to evolve.

Samphao S, Eremin JM, El-Sheemy M, Eremin O (2008) Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach. Ann Surg Oncol 15:1282–96PubMedCrossRef

Abrams JS (2001) Adjuvant therapy for breast cancer-results from the USA consensus conference. Breast Cancer 8:298–304PubMedCrossRef

Mills P, Sever A, Weeks J et al (2010) Axillary ultrasound assessment in primary breast cancer: an audit of 653 cases. Breast J 16:460–463PubMedCrossRef

Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98:599e609CrossRef

Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881e8CrossRef

Lucci A, McCall LM, Beitsch PD, American College of Surgeons Oncology Group et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group trial Z0011. J Clin Oncol 25:3657–3663PubMedCrossRef

Houssami N, Ciatto S, Turner RM, Cody HS III, Macaskill P (2011) Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla. Ann Surg 254:243e51CrossRef

Glynn RW, Williams L, Dixon JM (2010) A further survey of surgical management of the axilla in UK breast cancer patients. Ann R Coll Surg Eng 92:506–11CrossRef

http://www.nice.org.uk/nicemedia/pdf/CG80NICEGuideline.pdf. National Institute for Clinical excellence clinical guideline 80: Early and locally advanced breast cancer, diagnosis and treatment

10.

Rattay T, Muttalib M, Khalifa E, Duncan A, Parker SJ (2012) Clinical utility of routine pre-operative axillary ultrasound and fine needle aspiration cytology in patient selection for sentinel lymph node biopsy. Breast 21:210–4PubMedCrossRef

11.

Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569e75

12.

Giuliano AE, McCall L, Beitsch P et al (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252:426–32PubMed

13.

Solon JG, Power C, Al-Azawi D, Duke D, Hill AD (2012) Ultrasound-guided core biopsy: an effective method of detecting axillary nodal metastases. J Am Coll Surg 214:12–7PubMedCrossRef

14.

Carroll PA, O'Mahony D, McDermott R et al (2011) Perioperative diagnosis of the positive axilla in breast cancer: a safe, time efficient algorithm. Eur J Surg Oncol 37:205–10PubMedCrossRef

15.

Krag D, Weaver D, Ashikaga T et al (1998) The sentinel node in breast cancer–a multicenter validation study. N Engl JMed 339:941–946CrossRef

16.

Britton P, Moyle P, Benson JR et al (2010) Ultrasound of the axilla: where to look for the sentinel lymph node. Clin Radiol 65:373–376PubMedCrossRef

17.

National Institutes of Health (1991) NIH consensus conference on the treatment of early stage breast cancer. JAMA 265:391–395CrossRef

18.

Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703–20PubMedCrossRef

19.

Ivens D, Hoe AL, Podd TJ et al (1992) Assessment of morbidity from complete axillary dissection. Br J Cancer 66:136–138PubMedCentralPubMedCrossRef

20.

Duff M, Hill AD, McGreal G et al (2001) Prospective evaluation of the morbidity of axillary clearance for breast cancer. Br J Surg 88:114–117PubMedCrossRef

21.

Genta F, Zanon E, Camanni M et al (2007) Cost/accuracy ratio analysis in breast cancer patients undergoing ultrasound-guided fine-needle aspiration cytology, sentinel node biopsy, and frozen section of node. World J Surg 31:1155–63PubMedCrossRef

22.

Turaga KK, Chau A, Eatrides JM, Kiluk K et al (2011) Selective application of routine preoperative axillary ultrasonography reduces costs for invasive breast cancers. Oncologist 16:942–8PubMedCentralPubMedCrossRef

23.

Cools-Lartigue J, Meterissian S (2012) Accuracy of axillary ultrasound in the diagnosis of nodal metastasis in invasive breast cancer: a review. World J Surg 36:46–54, ReviewPubMedCrossRef

24.

Gnant M, Harbeck N, Thomssen C (2011) St Gallen 2011: summary of the consensus discussion. Breast Care 2011:136–41CrossRef

25.

Abe H, Schacht D, Sennett CA, Newstead GM, Schmidt RA (2013) Utility of preoperative ultrasound for predicting pN2 or higher stage axillary lymph node involvement in patients with newly diagnosed breast cancer. AJR 200:696–702PubMedCrossRef

Title: The Z0011 Trial: Is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients?
Authors: T. P. J. Farrell
N. C. Adams
M. Stenson
P. A. Carroll
M. Griffin
E. M. Connolly
S. A. O’Keeffe
Publication date: 01-09-2015
Publisher: Springer Berlin Heidelberg
Published in: European Radiology / Issue 9/2015
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-015-3683-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Z0011 Trial: Is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients?

Abstract

Objectives

Methods

Results

Conclusion

Key Points

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusion

Key Points

Please log in to get access to this content

Other articles of this Issue 9/2015

Digital Breast Tomosynthesis (DBT) to Characterize MRI-Detected Additional Lesions Unidentified at Targeted Ultrasound in Newly Diagnosed Breast Cancer Patients

Transient health symptoms of MRI staff working with 1.5 and 3.0 Tesla scanners in the UK

Quantification of tumour 18 F-FDG uptake: Normalise to blood glucose or scale to liver uptake?

CT-guided localization of small pulmonary nodules using adjacent microcoil implantation prior to video-assisted thoracoscopic surgical resection

Robust, fully automatic delineation of the head contour by stereotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphy

MRI findings of serous atrophy of bone marrow and associated complications